Literature DB >> 34814106

Zika Virus Seroprevalence in Two Districts of Chincha, Ica, Peru: A Cross-Sectional Study.

Rodrigo Cachay1, Alvaro Schwalb1, J Gonzalo Acevedo-Rodriguez1, Xiomara Merino1,2, Michael Talledo1,2, Luis Suarez-Ognio3, Laura Pezzi4, Xavier de Lamballerie4, Humberto Guerra1, Thomas Jaenisch5,6, Eduardo Gotuzzo1.   

Abstract

In 2017, a major outbreak of Zika virus (ZIKV) infection took place in Chincha Province, Peru, where arboviral circulation had never been reported before. We conducted a cross-sectional survey (March-May 2019) in two districts of Chincha Province: Pueblo Nuevo and Chincha Baja. We included residents who were 20 to 40 years old and who had lived in these districts for at least 1 year. Serological testing combined screening with a commercial NS1 protein-based Zika IgG ELISA, and confirmation by a cytopathic effect-based virus neutralization test (VNT). Prevalence ratios (PRs) were calculated using Poisson regression with robust error variance. Four hundred participants, divided equally among districts, were enrolled. Anti-ZIKV IgG ELISA was positive for 42 participants (10.5%) and borderline for 12 (3%). Fifty-two of these 54 samples were confirmed positive by ZIKV VNT (13% of the total population). The Pueblo Nuevo district exhibited a greater ZIKV seroprevalence based on VNT results than the Chincha Baja district (23.5% versus 2.5%), with participants from the Pueblo Nuevo district being 9.4 times more likely to have a positive ZIKV VNT result. Average monthly income greater than the minimum wage and adequate water storage were found to be protective factors (PR, 0.29 and 0.24, respectively). In multivariate analysis, living in the Pueblo Nuevo district and a personal history of fever and rash were strong predictors of ZIKV positivity by VNT. The low ZIKV seroprevalence should prompt health authorities to stimulate interventions to prevent potential future outbreaks. In the Pueblo Nuevo district, the seroprevalence was greater but presumably not sufficient to ensure protective herd immunity.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34814106      PMCID: PMC8733524          DOI: 10.4269/ajtmh.20-1339

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  17 in total

1.  Zika virus in asymptomatic blood donors in Martinique.

Authors:  Pierre Gallian; André Cabié; Pascale Richard; Laure Paturel; Rémi N Charrel; Boris Pastorino; Isabelle Leparc-Goffart; Pierre Tiberghien; Xavier de Lamballerie
Journal:  Blood       Date:  2016-11-08       Impact factor: 22.113

2.  Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region.

Authors:  Isabel Rodriguez-Barraquer; Federico Costa; Eduardo J M Nascimento; Nivison Nery; Priscila M S Castanha; Gielson Almeida Sacramento; Jaqueline Cruz; Mayara Carvalho; Daiana De Olivera; José E Hagan; Haritha Adhikarla; Elsio A Wunder; Danilo F Coêlho; Sasha R Azar; Shannan L Rossi; Nikos Vasilakis; Scott C Weaver; Guilherme S Ribeiro; Angel Balmaseda; Eva Harris; Maurício L Nogueira; Mitermayer G Reis; Ernesto T A Marques; Derek A T Cummings; Albert I Ko
Journal:  Science       Date:  2019-02-08       Impact factor: 47.728

3.  Zika Virus Associated with Microcephaly.

Authors:  Jernej Mlakar; Misa Korva; Nataša Tul; Mara Popović; Mateja Poljšak-Prijatelj; Jerica Mraz; Marko Kolenc; Katarina Resman Rus; Tina Vesnaver Vipotnik; Vesna Fabjan Vodušek; Alenka Vizjak; Jože Pižem; Miroslav Petrovec; Tatjana Avšič Županc
Journal:  N Engl J Med       Date:  2016-02-10       Impact factor: 91.245

4.  Zika Virus Infection in Pregnant Women in Rio de Janeiro.

Authors:  Patrícia Brasil; José P Pereira; M Elisabeth Moreira; Rita M Ribeiro Nogueira; Luana Damasceno; Mayumi Wakimoto; Renata S Rabello; Stephanie G Valderramos; Umme-Aiman Halai; Tania S Salles; Andrea A Zin; Dafne Horovitz; Pedro Daltro; Marcia Boechat; Claudia Raja Gabaglia; Patrícia Carvalho de Sequeira; José H Pilotto; Raquel Medialdea-Carrera; Denise Cotrim da Cunha; Liege M Abreu de Carvalho; Marcos Pone; André Machado Siqueira; Guilherme A Calvet; Ana E Rodrigues Baião; Elizabeth S Neves; Paulo R Nassar de Carvalho; Renata H Hasue; Peter B Marschik; Christa Einspieler; Carla Janzen; James D Cherry; Ana M Bispo de Filippis; Karin Nielsen-Saines
Journal:  N Engl J Med       Date:  2016-03-04       Impact factor: 91.245

5.  First report of autochthonous transmission of Zika virus in Brazil.

Authors:  Camila Zanluca; Vanessa Campos Andrade de Melo; Ana Luiza Pamplona Mosimann; Glauco Igor Viana Dos Santos; Claudia Nunes Duarte Dos Santos; Kleber Luz
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-06-09       Impact factor: 2.743

6.  Zika Virus Seroprevalence in Urban and Rural Areas of Suriname, 2017.

Authors:  Thomas Langerak; Tom Brinkman; Noreen Mumtaz; Georgina Arron; Sandra Hermelijn; Gaitree Baldewsingh; Merril Wongsokarijo; Lesley Resida; Barry Rockx; Marion P G Koopmans; Eric C M Van Gorp; Stephen Vreden
Journal:  J Infect Dis       Date:  2019-06-05       Impact factor: 5.226

7.  Zika virus and microcephaly: why is this situation a PHEIC?

Authors:  David L Heymann; Abraham Hodgson; Amadou Alpha Sall; David O Freedman; J Erin Staples; Fernando Althabe; Kalpana Baruah; Ghazala Mahmud; Nyoman Kandun; Pedro F C Vasconcelos; Silvia Bino; K U Menon
Journal:  Lancet       Date:  2016-02-11       Impact factor: 79.321

8.  Impact of Zika Virus Emergence in French Guiana: A Large General Population Seroprevalence Survey.

Authors:  Claude Flamand; Sarah Bailly; Camille Fritzell; Léna Berthelot; Jessica Vanhomwegen; Henrik Salje; Juliette Paireau; Séverine Matheus; Antoine Enfissi; Sandrine Fernandes-Pellerin; Félix Djossou; Sébastien Linares; Jean-François Carod; Mirdad Kazanji; Jean-Claude Manuguerra; Simon Cauchemez; Dominique Rousset
Journal:  J Infect Dis       Date:  2019-11-06       Impact factor: 5.226

9.  High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks.

Authors:  Eduardo Martins Netto; Andres Moreira-Soto; Celia Pedroso; Christoph Höser; Sebastian Funk; Adam J Kucharski; Alexandra Rockstroh; Beate M Kümmerer; Gilmara Souza Sampaio; Estela Luz; Sara Nunes Vaz; Juarez Pereira Dias; Fernanda Anjos Bastos; Renata Cabral; Thomas Kistemann; Sebastian Ulbert; Xavier de Lamballerie; Thomas Jaenisch; Oliver J Brady; Christian Drosten; Manoel Sarno; Carlos Brites; Jan Felix Drexler
Journal:  mBio       Date:  2017-11-14       Impact factor: 7.867

Review 10.  Current challenges and implications for dengue, chikungunya and Zika seroprevalence studies worldwide: A scoping review.

Authors:  Camille Fritzell; Dominique Rousset; Antoine Adde; Mirdad Kazanji; Maria D Van Kerkhove; Claude Flamand
Journal:  PLoS Negl Trop Dis       Date:  2018-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.